Jeffrey Jones, MD^1*, Anthony R. Mato, MD^2*, Steven Coutre, MD^3*, William Wierda, MD, PhD^4*, Michael Y. Choi, MD^5*, Matthew S. Davids, MD^6*, Nicole Lamanna, MD⁷, Paul Barr, MD^8*, Kim Burns, BA^9*, Nicholas Montalvo, MBA^9*, Ming Zhu, PhD^9*, Todd Busman, MS^9*, Jalaja Potluri, MD, FACP^9*, Rod A. Humerickhouse, MD, PhD⁹ and John C. Byrd, MD¹

¹The Ohio State University Medical Center, Columbus, OH
²Center for Chronic Lymphocytic Leukemia, University of Pennsylvania, Philadelphia, PA
³Stanford Cancer Center, Stanford University School of Medicine, Stanford, CA
⁴The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, TX
⁵University of California, San Diego, La Jolla, CA
⁶Dana Farber Cancer Institute, Boston, MA
⁷Columbia University Medical Center, New York, NY
⁸Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
⁹AbbVie Inc., North Chicago, IL

Adam Albitar^1*, Wanlong Ma, BS^1*, Ivan De Dios^1*, Jeffrey Estrella^1*, Mohammed Farooqui, DO², Adrian Wiestner, MD, PhD² and Maher Albitar¹

¹NeoGenomics Laboratories, Irvine, CA
²Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD

Heidi D. Finnes, PharmD^1*, Kari G. Chaffee, MS^2*, Timothy G. Call, MD³, Wei Ding, MD, PhD³, Deborah A. Bowen, APRN, CNP^3*, Michael Conte, PA-C^3*, Kristen B. McCullough, PharmD^1*, Julianna A. Merten, PharmD^1*, Gabriel T. Bartoo, PharmD^1*, Matthew D. Smith, PharmD^1*, Susan M. Schwager^4*, Susan L. Slager, PhD⁵, Neil E. Kay, MD³, Tait D. Shanafelt, MD³ and Sameer A. Parikh, MD³

¹Department of Pharmacy Services, Mayo Clinic, Rochester, MN
²Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN
³Division of Hematology, Mayo Clinic, Rochester, MN
⁴Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
⁵Department of Health Sciences Research, Mayo Clinic, Rochester, MN

Lukas Kazianka^1*, Christa Drucker^2*, Cathrin Skrabs, MD^1*, Philipp Bernhard Staber, MD, PhD^3*, Edit Anna Porpaczy, MD, PhD^3*, Christine Einberger^1*, Marion Heinz^1*, Alexander Hauswirth, MD^1*, Ingrid Pabinger, MD¹, Peter Quehenberger, MD^4*, Bernd Jilma, MD² and Ulrich Jaeger, MD¹

¹Dept. of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
²Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
³Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
⁴Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, Vienna, Austria

Anthony Mato, MD^1*, Chadi Nabhan, MD², Paul M. Barr, MD³, Chaitra S. Ujjani, MD⁴, Brian T. Hill, MD, PhD⁵, Nicole Lamanna, MD⁶, Alan P Skarbnik, MD⁷, Christina Howlett, PharmD, BCOP^7*, Jeffrey J Pu, MD, PhD⁸, Alison R. Sehgal, MD⁹, Lauren E. Strelec, BA^1*, Alexandra Vandegrift, BA^1*, Allison Rago, BSN^10*, Clive S Zent, MD¹¹, Tatyana Feldman, MD¹², Andre Goy, MD¹³, David F. Claxton, MD⁸, Spencer Henick Bachow, MD^6*, Gurbakhash Kaur, MD, BS, MA^14*, Jakub Svoboda, MD¹, Sunita Dwivedy Nasta, MD¹, David Porter, MD¹, Daniel J. Landsburg, MD¹, Stephen J. Schuster, MD¹, Bruce D. Cheson, MD⁴ and Andrew M. Evens, DO, MSc¹⁴

¹Center for Chronic Lymphocytic Leukemia, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
²Department of Medicine, Section of Hematology and Oncology, The University of Chicago, Chicago, IL
³University of Rochester, Rochester, NY
⁴Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC
⁵Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
⁶Columbia University Medical Center, New York, NY
⁷Hackensack University Medical Center, Hackensack, NJ
⁸Penn State Hershey Cancer Institute, Hershey, PA
⁹University of Pittsburgh Medical Center, Pittsburgh, PA
¹⁰Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
¹¹Wilmot Cancer Institute, University of Rochester, Rochester, NY
¹²John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
¹³John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ
¹⁴Tufts Medical Center Cancer Center, Boston, MA

Natalie Dimier^1*, Paul Delmar^2*, Carol Ward^2*, Rodica Morariu-Zamfir^2*, Gunter Fingerle-Rowson², Jasmin Bahlo^3*, Kirsten Fischer, MD^3*, Barbara F. Eichhorst, MD³, Valentin Goede, MD^3,4*, Jacques J.M. van Dongen, MD⁵, Matthias Ritgen, MD^6*, Sebastian Böttcher, MD^7*, Anton W. Langerak^8*, Michael Kneba⁹ and Michael Hallek, MD³

¹F. Hoffmann-La Roche Ltd, Welwyn, United Kingdom
²F. Hoffmann-La Roche Ltd, Basel, Switzerland
³Department I of Internal Medicine, Center of Integrated Oncology Cologne-Bonn, University Hospital Cologne, Cologne, Germany
⁴German CLL Study Group, Department I of Internal Medicine, Center of Integrated Oncology Cologne-Bonn, University Hospital Cologne, Cologne, Germany
⁵Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, Netherlands
⁶Second Department of Medicine, University of Schleswig-Holstein, Kiel, Germany
⁷Campus Kiel, University Hospital of Schleswig-Holstein, Kiel, Germany
⁸Department of Immunology, Erasmus MC Rotterdam, Rotterdam, Netherlands
⁹Department of Hematology, University Hospital Schleswig-Holstein, Kiel, Germany